Because the leg is known to exhibit springlike behavior during the stance phase of running, several exoskeletons have attempted to place external springs in parallel with some or all of the leg during stance, but these designs have failed to permit natural kinematics during swing. To this end, a parallel-elastic exoskeleton is presented that introduces a clutch to disengage the parallel leg-spring and thereby not constrain swing-phase movements of the biological leg. A custom interference clutch with integrated planetary gear transmission, made necessary by the requirement for high holding torque but low mass, is presented and shown to withstand up to 190 N·m at 1.8 deg resolution with a mass of only 710 g. A suitable control strategy for locking the clutch at peak knee extension is also presented, where only an onboard rate gyroscope and exoskeletal joint encoder are employed as sensory inputs. Exoskeletal electromechanics, sensing, and control are shown to achieve design critieria necessary to emulate biological knee stiffness behaviors in running.
Abstract-While the effects of series compliance on running biomechanics are well documented, the effects of parallel compliance are known only for the simpler case of hopping. As many practical exoskeletal and orthotic designs act in parallel with the leg, it is desirable to understand the effects of such an intervention. Spring-like forces offer a natural choice of perturbation for running, as they are both biologically motivated and energetically inexpensive to implement. To this end, we investigate the hypothesis that the addition of an external elastic element at the knee during the stance phase of running results in a reduction in knee extensor activation so that total joint quasistiffness is maintained. An exoskeletal knee brace consisting of an elastic element engaged by a clutch is used to provide this stance phase extensor torque. Motion capture of five subjects is used to investigate the consequences of running with this device. No significant change in leg stiffness or total knee stiffness is observed due to the activation of the clutched parallel knee spring. However, this pilot data suggests differing responses between casual runners and competitive long-distance runners, whose total knee torque is increased by the device. Such a relationship between past training and effective utilization of an external force is suggestive of limitations on the applicability of assistive devices.
This paper examines the impact of a biomimetic active knee prosthesis on the metabolic costs associated with a unilateral transfemoral amputee walking at self selected speed. In this study we compare the antagonistic active knee prosthesis developed at MIT to an electronically controlled, variable-damping commercial knee prosthesis, the Otto Bock C-leg. Use of the active knee prosthesis resulted in both, a 17% increase in an amputee's average self selected walking speed from 1.12 m/s to 1.31 m/s, and a 6.8% reduction in metabolic cost. The results of this study suggest that an agonist-antagonist active knee prosthesis design with variable impedance control can offer walking energetic advantages over commercially available systems.
The majority of commercial prosthetic knees are passive in nature and therefore cannot replicate the positive mechanical work exhibited by the natural human knee in early and late stance. In contrast to traditional purely dissipative prosthetic knees, we propose a biomimetic active agonist-antagonist structure designed to reproduce both positive and negative work phases of the natural joint while using series elasticity to minimize net energy consumption. We present the design and implementation of the active knee prosthesis prototype.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.